Before you continue…
This website has been developed by Novo Nordisk UK to provide
information to GB-based adult patients who have been prescribed
Wegovy®.
The information on this website does
not replace the patient information leaflet, which you are advised to
read in full. It is not intended as a substitute for clinical advice
provided by your healthcare professional. Please contact your
healthcare professional if you have any questions about your treatment
and for clinical advice.
To ensure you receive the
information that meets your needs, please tell us who you are:
I am a member of the public based in the UK →
I am a healthcare professional or other relevant decision maker based in Great Britain →
I am an adolescent patient aged 12–17 years old who has been prescribed Wegovy® or their carer →
Reporting side effects
This medicine is subject to additional
monitoring. This will allow quick identification of new safety
information promptly. You can help by reporting any side effects you
may get. See https://yellowcard.mhra.gov.uk/ for how to report
side effects.
If you get any side effects, talk to your
doctor, pharmacist or nurse. This includes any possible side effects
not listed in the package leaflet. You can also report side effects
directly via the Yellow Card Scheme at
https://yellowcard.mhra.gov.uk/. Side effects
should also be reported to Novo Nordisk Limited (Telephone Novo
Nordisk Customer Care Centre 0800 023 2573). Calls may be monitored
for training purposes. By reporting side effects, you can help provide
more information on the safety of this medicine.